Work

ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition

Year: 2018

Type: article

Abstract: Publisher's Note: There is a Blood Commentary on this article in this issue.

Source: Blood

DOI: 10.1182/blood-2018-05-849554

Authors: Kathryn G. Roberts, Laura J. Janke, Yaqi Zhao, Aman Seth, Jing Ma, David Finkelstein, Steve Smith, Kevin Ebata, Brian B. Tuch, Stephen P. Hunger, Charles G. Mullighan

Institutions: St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, University of Pennsylvania

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Leukemia and Lymphoma Society, Children's Hospital of Philadelphia, St. Jude Children's Research Hospital, American Lebanese Syrian Associated Charities, Plexxikon, National Institutes of Health, Loxo Oncology, National Cancer Institute, National Institute of General Medical Sciences

Awards: G169511485, G2554726104, G5223741575, G7617439221, Translating genomic discoveries to improved outcomes for high risk acute leukemia

OpenAlex ID: W2806522835

FWCI: 6.823

Cites: 23

Cited by: 72

Related to: 10